Effect of nm23 gene expression on the survival and other prognostic indexes of patients with breast cancer
Yong Zhang,Xue-wei Yang
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.42.054
2005-01-01
Abstract:AIM: To investigate the influence of the expression of nm23 gene on the prognosis in patients with breast cancer. METHODS: Sixty female patients with breast cancer of 26-63 years old, who received radical treatment in the Department of General Surgery, the Second Affiliated Hospital of Harbin Medical University from June 1997 to December 1998, participated in the study, including 30 cases had transfer of axillary lymph node and 30 cases had no transfer of axillary lymph node. According to the clinical staging standard of International Anti-Cancer Association, the patients were classified into 30 cases of stage, 16 cases of stage Ⅱ, 14 cases of stage Ⅲ and none was stage Ⅳ, another 20 patients with breast cystic hyperplasia at the same period were randomly selected as controls. The expression of nm23 gene was detected with immunohistochemical S-P method in both groups, and the associations of the positive expression of nm23 gene with the clinical pathological indexes, distant transfer and survival rate were observed. The buffy cell plasm was taken as the positive expression of nm23 gene. RESULTS: All the 60 patients with breast cancer and 20 patients with breast cystic hyperplasia were involved in the analysis of results. ① The positive expression of nm23 gene in breast cancer and breast cystic hyperplasia: It was significantly higher in breast cancer than in breast cystic hyperplasia (60.0%, 30.0%, P < 0.05). ② Association between the positive expression of nm23 gene and clinical pathological indexes: The positive expression rate of nm23 gene was significantly higher in patients of clinical stages Ⅰ-Ⅱ than in those of stage Ⅲ (67.4%, 35.7%, P < 0.05), significantly higher in patients without transfer of axillary lymph node than in those with transfer of axillary lymph node (86.7%, 33.3%, P <0.05), significantly higher in patients with hormone receptor (+) than in those with hormone receptor (-) (72.7%, 25.0%, P < 0.05), also significantly higher in the patients with progestogen receptor (+) than in those with progestogen receptor (-) (75.0%, 30.0%, P < 0.05). ③ Correlation of the positive expression of nm23 gene with distant transfer and survival rate: The positive expression of nm23 gene was significantly higher in the patients without distant transfer those with distant transfer (73.4%, 14.3%, P < 0.05), and survival rate of 5 years was significantly higher in the patients with positive expression of nm23 gene than in those with negative ones (94.4%, 50.0%, P < 0.05). CONCLUSION: It is the most helpful in evaluating the prognosis of patients with breast cancer and directing clinical treatment to observe the expression of nm23 gene.